BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2016

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three months ended March 31, 2016 and 2015 are as follows:

	Three Months Ended
	March 31,
	2016				2015
Laser systems		62.3	%			64.6	%
Imaging systems		6.3	%			3.1	%
Consumables and other		16.1	%			17.5	%
Services		15.0	%			13.8	%
License fees and royalties		0.3	%			1.0	%
Total revenue		100.0	%			100.0	%